How do I install the Endo Lipid Panel Assessment Initial Screening skill?

Run npx skillmds@latest add dromlakhani/endo-lipid-panel-assessment-initial-screening in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Lipid Panel Assessment Initial Screening safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Lipid Panel Assessment Initial Screening?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Lipid Panel Assessment Initial Screening free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Lipid Panel Assessment Initial Screening?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Lipid Panel Assessment Initial Screening by dromlakhani

Name: Endo Lipid Panel Assessment Initial Screening
Rating: 4.2 (5 reviews)
Author: dromlakhani

Endo Lipid Panel Assessment Initial Screening

Recommends obtaining a lipid panel to assess triglyceride levels and calculate LDL-C for initial screening in adults with endocrine disorders. Triggered when a clinician requests initial lipid assessment in a patient with known endocrine disorder such as diabetes, thyroid disease, or obesity.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Lipid panel assessment for initial screening in endocrine disorders

STEP 1 — Gather Information

Confirm adult patient has a diagnosed endocrine disorder (e.g., diabetes mellitus, thyroid disease, obesity, PCOS, Cushing syndrome) and that no lipid panel has been obtained recently for initial screening; note whether patient is fasting or non-fasting.

STEP 2 — Rule In / Rule Out

If the patient has an endocrine disorder and requires initial lipid assessment, proceed to obtain a lipid panel; otherwise, lipid panel screening is not indicated at this time.

STEP 3 — Classify or Stratify

Obtain a lipid panel (non-fasting acceptable for initial screening); measure total cholesterol, HDL-C, and triglycerides; calculate LDL-C using the Friedewald equation if triglycerides <400 mg/dL, or consider alternative methods if triglycerides are elevated; classify triglyceride levels as normal (<150 mg/dL) or elevated (≥150 mg/dL) and LDL-C as per risk categories.

STEP 4 — Decide

If triglyceride levels are elevated (≥150 mg/dL) or genetic dyslipidemia is suspected, repeat a fasting lipid panel; use the triglyceride and LDL-C values to inform cardiovascular risk assessment and guide further management per endocrine disorder–specific guidelines.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on non-fasting lipid panels if triglyceride levels are >400 mg/dL or if genetic dyslipidemia is suspected; avoid delaying repeat fasting panel when initial non-fasting triglycerides are elevated, as this may miss clinically significant hypertriglyceridemia.

Concrete Clinical Example

A 50-year-old man with newly diagnosed type 2 diabetes undergoes initial lipid screening; non-fasting panel shows triglycerides 165 mg/dL, total cholesterol 210 mg/dL, HDL-C 38 mg/dL, LDL-C calculated 130 mg/dL; due to elevated triglycerides, a fasting lipid panel is ordered to confirm results before initiating lifestyle intervention.

Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, DOI:10.1210/clinem/dgaa674

---name: endo-lipid-panel-assessment-initial-screeningdescription: Recommends obtaining a lipid panel to assess triglyceride levels and calculate LDL-C for initial screening in adults with endocrine disorders. Triggered when a clinician requests initial lipid assessment in a patient with known endocrine disorder such as diabetes, thyroid disease, or obesity.---# Lipid panel assessment for initial screening in endocrine disorders## STEP 1 — Gather InformationConfirm adult patient has a diagnosed endocrine disorder (e.g., diabetes mellitus, thyroid disease, obesity, PCOS, Cushing syndrome) and that no lipid panel has been obtained recently for initial screening; note whether patient is fasting or non-fasting.## STEP 2 — Rule In / Rule OutIf the patient has an endocrine disorder and requires initial lipid assessment, proceed to obtain a lipid panel; otherwise, lipid panel screening is not indicated at this time.## STEP 3 — Classify or StratifyObtain a lipid panel (non-fasting acceptable for initial screening); measure total cholesterol, HDL-C, and triglycerides; calculate LDL-C using the Friedewald equation if triglycerides <400 mg/dL, or consider alternative methods if triglycerides are elevated; classify triglyceride levels as normal (<150 mg/dL) or elevated (≥150 mg/dL) and LDL-C as per risk categories.## STEP 4 — DecideIf triglyceride levels are elevated (≥150 mg/dL) or genetic dyslipidemia is suspected, repeat a fasting lipid panel; use the triglyceride and LDL-C values to inform cardiovascular risk assessment and guide further management per endocrine disorder–specific guidelines.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on non-fasting lipid panels if triglyceride levels are >400 mg/dL or if genetic dyslipidemia is suspected; avoid delaying repeat fasting panel when initial non-fasting triglycerides are elevated, as this may miss clinically significant hypertriglyceridemia.## Concrete Clinical ExampleA 50-year-old man with newly diagnosed type 2 diabetes undergoes initial lipid screening; non-fasting panel shows triglycerides 165 mg/dL, total cholesterol 210 mg/dL, HDL-C 38 mg/dL, LDL-C calculated 130 mg/dL; due to elevated triglycerides, a fasting lipid panel is ordered to confirm results before initiating lifestyle intervention.**Source:** Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, DOI:10.1210/clinem/dgaa674

Frequently asked questions